FDA Inspection 1285158 — Eurofins BioPharma Product Testing Spain SLU
The FDA completed an inspection of Eurofins BioPharma Product Testing Spain SLU on January 13, 2022 in Esplugues De Llobregat. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 13, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Esplugues De Llobregat (Spain)
Additional Details
Mutual Recognition Agreement (MRA)